Sahin Umut, de Thé Hugues, Lallemand-Breitenbach Valérie
a University Paris Diderot; Sorbonne Paris Cité ; Hôpital St. Louis ; Paris , France.
Nucleus. 2014;5(6):499-507. doi: 10.4161/19491034.2014.970104.
PML Nuclear Bodies (NBs) have fascinated cell biologists due to their exquisitely dynamic nature and their involvement in human diseases, notably acute promyelocytic leukemia. NBs, as well as their master organizer--the PML protein--exhibit multiple connections with stress responses. Initially viewed as a tumor suppressor, PML recently re-emerged as a multifaceted protein, capable of controlling numerous aspects of cellular homeostasis. NBs recruit many functionally diverse proteins and function as stress-regulated sumoylation factories. SUMO-initiated partner retention can subsequently facilitate a variety of other post-translational modifications, as well as partner degradation. With this newly elucidated central role of stress-enhanced sumoylation, it should now be possible to build a working model for the different NB-regulated cellular activities. Moreover, pharmacological manipulation of NB formation by interferons or oxidants holds the promise of clearing many undesirable proteins for clinical management of malignant, viral or neurodegenerative diseases.
早幼粒细胞白血病核小体(NBs)因其极其动态的性质以及与人类疾病(尤其是急性早幼粒细胞白血病)的关联,一直吸引着细胞生物学家。核小体以及它们的主要组织者——早幼粒细胞白血病蛋白(PML蛋白)——与应激反应存在多种联系。PML蛋白最初被视为一种肿瘤抑制因子,最近又重新成为一种具有多面功能的蛋白质,能够控制细胞内稳态的多个方面。核小体招募许多功能各异的蛋白质,并作为应激调节的类泛素化工厂发挥作用。随后,由类泛素化引发的伴侣蛋白保留可促进多种其他翻译后修饰以及伴侣蛋白降解。鉴于应激增强的类泛素化这一新阐明的核心作用,现在应该有可能构建一个关于不同核小体调节的细胞活动的工作模型。此外,通过干扰素或氧化剂对核小体形成进行药理学调控,有望清除许多不良蛋白质,用于恶性、病毒或神经退行性疾病的临床治疗。